Patient Access
Also: Anumana receives FDA Breakthrough Device Designation for its ECG-based algorithm designed for early detection of pulmonary hypertension, and AI-enabled imaging companies Aidoc and Gleamer partner.
The company launched in December with a $2.8 million seed.
Researchers found a 43.4% mean reduction in patient-rated obsessive-compulsive symptoms.
The app has been recommended as an effective alternative to sleeping pills in the UK.
Also: Pear Therapeutics reported $2.7 million in revenue for its first quarter compared with $1.3 million in Q4 2021.
On the heels of a $9.2 million Series A, Mahmee CEO and cofounder Melissa Hanna discusses the fragmented maternal healthcare experience in the U.S.
The solution uses gamification to increase patient adherence.
Also: Women's healthcare provider Tia expands into fertility care.
The startup launched in August last year with a $3.2 million seed.
Cerebral is halting prescriptions such as Adderall and Xanax for current and new patients.